These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 27797225

  • 1. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G, Ak S, Eskiler GG, Demirdogen E, Erturk E, Gokgoz S, Polatkan V, Egeli U, Tunca B, Tezcan G, Topal U, Tolunay S, Tasdelen I.
    Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
    [Abstract] [Full Text] [Related]

  • 2. Circulating microRNA-based screening tool for breast cancer.
    Frères P, Wenric S, Boukerroucha M, Fasquelle C, Thiry J, Bovy N, Struman I, Geurts P, Collignon J, Schroeder H, Kridelka F, Lifrange E, Jossa V, Bours V, Josse C, Jerusalem G.
    Oncotarget; 2016 Feb 02; 7(5):5416-28. PubMed ID: 26734993
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM, Luo B, Ye NY, Xie K, Ye SR.
    Clin Exp Metastasis; 2006 Feb 02; 23(5-6):279-89. PubMed ID: 17086357
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
    Skondra M, Gkioka E, Kostakis ID, Pissimissis N, Lembessis P, Pectasides D, Koutsilieris M.
    Anticancer Res; 2014 Nov 02; 34(11):6691-9. PubMed ID: 25368276
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM, Makar WS, Kassem HA, Talima S, Tarek M, Hesham H, El-Desouky MA.
    Asian Pac J Cancer Prev; 2019 Sep 01; 20(9):2749-2755. PubMed ID: 31554373
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
    Li JY, Zhang Y, Zhang WH, Jia S, Kang Y, Tian R.
    Asian Pac J Cancer Prev; 2013 Sep 01; 14(3):1715-20. PubMed ID: 23679262
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
    Mar-Aguilar F, Luna-Aguirre CM, Moreno-Rocha JC, Araiza-Chávez J, Trevino V, Rodríguez-Padilla C, Reséndez-Pérez D.
    Asia Pac J Clin Oncol; 2013 Mar 01; 9(1):53-9. PubMed ID: 22898264
    [Abstract] [Full Text] [Related]

  • 14. Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.
    Yadav P, Mirza M, Nandi K, Jain SK, Kaza RC, Khurana N, Ray PC, Saxena A.
    Tumour Biol; 2016 Nov 01; 37(11):15275-15282. PubMed ID: 27696295
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
    Chen W, Cai F, Zhang B, Barekati Z, Zhong XY.
    Tumour Biol; 2013 Feb 01; 34(1):455-62. PubMed ID: 23238818
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters.
    Swellam M, El Magdoub HM, Hassan NM, Hefny MM, Sobeih ME.
    Clin Biochem; 2018 Jun 01; 56():47-54. PubMed ID: 29679553
    [Abstract] [Full Text] [Related]

  • 19. MiR-4728-3p could act as a marker of HER2 status.
    Li H, Zhou X, Zhu J, Cheng W, Zhu W, Shu Y, Liu P.
    Cancer Biomark; 2015 Jun 01; 15(6):807-14. PubMed ID: 26406406
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.